132 related articles for article (PubMed ID: 31620234)
41. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
42. An unexpected role for the active site base in cofactor orientation and flexibility in the copper amine oxidase from Hansenula polymorpha.
Plastino J; Green EL; Sanders-Loehr J; Klinman JP
Biochemistry; 1999 Jun; 38(26):8204-16. PubMed ID: 10387066
[TBL] [Abstract][Full Text] [Related]
43. DNA adducts from N-nitrosodiethanolamine and related beta-oxidized nitrosamines in vivo: (32)P-postlabeling methods for glyoxal- and O(6)-hydroxyethyldeoxyguanosine adducts.
Loeppky RN; Ye Q; Goelzer P; Chen Y
Chem Res Toxicol; 2002 Apr; 15(4):470-82. PubMed ID: 11952332
[TBL] [Abstract][Full Text] [Related]
44. Scaffold Morphing To Identify Novel DprE1 Inhibitors with Antimycobacterial Activity.
R MM; Shandil R; Panda M; Sadler C; Ambady A; Panduga V; Kumar N; Mahadevaswamy J; Sreenivasaiah M; Narayan A; Guptha S; Sharma S; Sambandamurthy VK; Ramachandran V; Mallya M; Cooper C; Mdluli K; Butler S; Tommasi R; Iyer PS; Narayanan S; Chatterji M; Shirude PS
ACS Med Chem Lett; 2019 Oct; 10(10):1480-1485. PubMed ID: 31620237
[TBL] [Abstract][Full Text] [Related]
45. DprE1--from the discovery to the promising tuberculosis drug target.
Mikusová K; Makarov V; Neres J
Curr Pharm Des; 2014; 20(27):4379-403. PubMed ID: 24245764
[TBL] [Abstract][Full Text] [Related]
46. A convenient method for palladium-catalyzed reductive deuteration of organic substrates using deuterated hypophosphite in D2O.
Oba M
J Labelled Comp Radiopharm; 2015 May; 58(5):215-9. PubMed ID: 25732435
[TBL] [Abstract][Full Text] [Related]
47. Synthesis and structure-activity relationships evaluation of benzothiazinone derivatives as potential anti-tubercular agents.
Gao C; Ye TH; Wang NY; Zeng XX; Zhang LD; Xiong Y; You XY; Xia Y; Xu Y; Peng CT; Zuo WQ; Wei Y; Yu LT
Bioorg Med Chem Lett; 2013 Sep; 23(17):4919-22. PubMed ID: 23886691
[TBL] [Abstract][Full Text] [Related]
48. Substrate and solvent isotope effects on the fate of the active oxygen species in substrate-modulated reactions of putidamonooxin.
Twilfer H; Sandfort G; Bernhardt FH
Eur J Biochem; 2000 Oct; 267(19):5926-34. PubMed ID: 10998052
[TBL] [Abstract][Full Text] [Related]
49. 4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity.
Naik M; Humnabadkar V; Tantry SJ; Panda M; Narayan A; Guptha S; Panduga V; Manjrekar P; Jena LK; Koushik K; Shanbhag G; Jatheendranath S; Manjunatha MR; Gorai G; Bathula C; Rudrapatna S; Achar V; Sharma S; Ambady A; Hegde N; Mahadevaswamy J; Kaur P; Sambandamurthy VK; Awasthy D; Narayan C; Ravishankar S; Madhavapeddi P; Reddy J; Prabhakar K; Saralaya R; Chatterji M; Whiteaker J; McLaughlin B; Chiarelli LR; Riccardi G; Pasca MR; Binda C; Neres J; Dhar N; Signorino-Gelo F; McKinney JD; Ramachandran V; Shandil R; Tommasi R; Iyer PS; Narayanan S; Hosagrahara V; Kavanagh S; Dinesh N; Ghorpade SR
J Med Chem; 2014 Jun; 57(12):5419-34. PubMed ID: 24871036
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and docking studies of pyrazine-thiazolidinone hybrid scaffold targeting dormant tuberculosis.
Chitre TS; Asgaonkar KD; Miniyar PB; Dharme AB; Arkile MA; Yeware A; Sarkar D; Khedkar VM; Jha PC
Bioorg Med Chem Lett; 2016 May; 26(9):2224-8. PubMed ID: 27017114
[TBL] [Abstract][Full Text] [Related]
51. Spirocyclic and Bicyclic 8-Nitrobenzothiazinones for Tuberculosis with Improved Physicochemical and Pharmacokinetic Properties.
Zhang G; Howe M; Aldrich CC
ACS Med Chem Lett; 2019 Mar; 10(3):348-351. PubMed ID: 30891138
[TBL] [Abstract][Full Text] [Related]
52. Structural studies of Mycobacterium tuberculosis DprE1 interacting with its inhibitors.
Piton J; Foo CS; Cole ST
Drug Discov Today; 2017 Mar; 22(3):526-533. PubMed ID: 27666194
[TBL] [Abstract][Full Text] [Related]
53. 2-Carboxyquinoxalines kill mycobacterium tuberculosis through noncovalent inhibition of DprE1.
Neres J; Hartkoorn RC; Chiarelli LR; Gadupudi R; Pasca MR; Mori G; Venturelli A; Savina S; Makarov V; Kolly GS; Molteni E; Binda C; Dhar N; Ferrari S; Brodin P; Delorme V; Landry V; de Jesus Lopes Ribeiro AL; Farina D; Saxena P; Pojer F; Carta A; Luciani R; Porta A; Zanoni G; De Rossi E; Costi MP; Riccardi G; Cole ST
ACS Chem Biol; 2015 Mar; 10(3):705-14. PubMed ID: 25427196
[TBL] [Abstract][Full Text] [Related]
54. Studies on the nitroreductase prodrug-activating system. Crystal structures of complexes with the inhibitor dicoumarol and dinitrobenzamide prodrugs and of the enzyme active form.
Johansson E; Parkinson GN; Denny WA; Neidle S
J Med Chem; 2003 Sep; 46(19):4009-20. PubMed ID: 12954054
[TBL] [Abstract][Full Text] [Related]
55. Insight into the mechanism of aromatic hydroxylation by toluene 4-monooxygenase by use of specifically deuterated toluene and p-xylene.
Mitchell KH; Rogge CE; Gierahn T; Fox BG
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):3784-9. PubMed ID: 12640145
[TBL] [Abstract][Full Text] [Related]
56. Hydride-Meisenheimer complex formation and protonation as key reactions of 2,4,6-trinitrophenol biodegradation by Rhodococcus erythropolis.
Rieger PG; Sinnwell V; Preuss A; Francke W; Knackmuss HJ
J Bacteriol; 1999 Feb; 181(4):1189-95. PubMed ID: 9973345
[TBL] [Abstract][Full Text] [Related]
57. Reductive Activity and Mechanism of Hypoxia- Targeted AGT Inhibitors: An Experimental and Theoretical Investigation.
Xiao W; Sun G; Fan T; Liu J; Zhang N; Zhao L; Zhong R
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31847200
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and Antitubercular Activity of New Benzo[b]thiophenes.
Mahajan PS; Nikam MD; Nawale LU; Khedkar VM; Sarkar D; Gill CH
ACS Med Chem Lett; 2016 Aug; 7(8):751-6. PubMed ID: 27563398
[TBL] [Abstract][Full Text] [Related]
59. Deuterium isotope effects in drug pharmacokinetics II: Substrate-dependence of the reaction mechanism influences outcome for cytochrome P450 cleared drugs.
Sun H; Piotrowski DW; Orr STM; Warmus JS; Wolford AC; Coffey SB; Futatsugi K; Zhang Y; Vaz ADN
PLoS One; 2018; 13(11):e0206279. PubMed ID: 30427871
[TBL] [Abstract][Full Text] [Related]
60. Electrochemical characteristics of nitro-heterocyclic compounds of biological interest. III. Nitroso derivative formation.
Tocher JH; Edwards DI
Free Radic Res Commun; 1989; 5(6):327-32. PubMed ID: 2925100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
